{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:28:17Z","timestamp":1789730897549,"version":"4.0.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11883-019-0801-y","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T04:24:23Z","timestamp":1564201463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis"],"prefix":"10.1007","volume":"21","author":[{"given":"Sanjiv","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avtar Singh","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,27]]},"reference":[{"issue":"6423","key":"801_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801\u20139.","journal-title":"Nature"},{"issue":"6801","key":"801_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233\u201341.","journal-title":"Nature"},{"issue":"6917","key":"801_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374.","journal-title":"Nature"},{"issue":"32","key":"801_CR4","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1021\/acs.biochem.6b00469","volume":"55","author":"B Zeya","year":"2016","unstructured":"Zeya B, Arjuman A, Chandra NC. Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1): a chameleon receptor for oxidized LDL. Biochemistry. 2016;55(32):4437\u201344.","journal-title":"Biochemistry"},{"issue":"1","key":"801_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","volume":"69","author":"JL Mehta","year":"2006","unstructured":"Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res. 2006;69(1):36\u201345.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"801_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.immuni.2014.09.019","volume":"41","author":"R Brink","year":"2014","unstructured":"Brink R. LOX-1 unlocks human plasma cell potential. Immunity. 2014;41(4):507\u20138.","journal-title":"Immunity"},{"issue":"8","key":"801_CR7","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1089\/ars.2010.3792","volume":"15","author":"J Lu","year":"2011","unstructured":"Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal. 2011;15(8):2301\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"16","key":"801_CR8","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","volume":"70","author":"S Xu","year":"2013","unstructured":"Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci : CMLS. 2013;70(16):2859\u201372.","journal-title":"Cell Mol Life Sci : CMLS"},{"key":"801_CR9","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/152786","volume":"2013","author":"A Pirillo","year":"2013","unstructured":"Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediat Inflamm. 2013;2013:152786.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"801_CR10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.HYP.35.4.904","volume":"35","author":"H Ikeda","year":"2000","unstructured":"Ikeda H, Takajo Y, Murohara T, Ichiki K, Adachi H, Haramaki N, et al. Platelet-derived nitric oxide and coronary risk factors. Hypertension. 2000;35(4):904\u20137.","journal-title":"Hypertension"},{"issue":"2","key":"801_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.ATV.11.2.254","volume":"11","author":"PM Bath","year":"1991","unstructured":"Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11(2):254\u201360.","journal-title":"Arterioscler Thromb"},{"issue":"1","key":"801_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(02)00236-X","volume":"95","author":"M Chen","year":"2002","unstructured":"Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther. 2002;95(1):89\u2013100.","journal-title":"Pharmacol Ther"},{"issue":"24","key":"801_CR13","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/01.CIR.99.24.3110","volume":"99","author":"H Kataoka","year":"1999","unstructured":"Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999;99(24):3110\u20137.","journal-title":"Circulation"},{"issue":"1","key":"801_CR14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1050-1738(01)00079-2","volume":"11","author":"N Kume","year":"2001","unstructured":"Kume N, Kita T. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med. 2001;11(1):22\u20135.","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"801_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10557-011-6341-5","volume":"25","author":"S Mitra","year":"2011","unstructured":"Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 2011;25(5):419\u201329.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"801_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2012.10.020","volume":"428","author":"A Pirillo","year":"2012","unstructured":"Pirillo A, Uboldi P, Ferri N, Corsini A, Kuhn H, Catapano AL. Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins. Biochem Biophys Res Commun. 2012;428(2):230\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"801_CR17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.atherosclerosis.2008.07.012","volume":"203","author":"SW Shiu","year":"2009","unstructured":"Shiu SW, Tan KC, Wong Y, Leng L, Bucala R. Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus. Atherosclerosis. 2009;203(2):522\u20137.","journal-title":"Atherosclerosis"},{"issue":"Suppl 48","key":"801_CR18","doi-asserted-by":"crossref","first-page":"9s","DOI":"10.1042\/CS103S009S","volume":"103","author":"H Morawietz","year":"2002","unstructured":"Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, Holtz J. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1. Clin Sci (Lond). 2002;103(Suppl 48):9s\u201312s.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"801_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","volume":"19","author":"AJ Kattoor","year":"2017","unstructured":"Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42.","journal-title":"Curr Atheroscler Rep"},{"issue":"17","key":"801_CR20","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1074\/jbc.275.17.12633","volume":"275","author":"L Cominacini","year":"2000","unstructured":"Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275(17):12633\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"801_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2007.01.004","volume":"47","author":"XP Chen","year":"2007","unstructured":"Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vasc Pharmacol. 2007;47(1):1\u20139.","journal-title":"Vasc Pharmacol"},{"issue":"3","key":"801_CR22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(02)02811-5","volume":"41","author":"L Cominacini","year":"2003","unstructured":"Cominacini L, Fratta Pasini A, Garbin U, Pastorino A, Rigoni A, Nava C, et al. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol. 2003;41(3):499\u2013507.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"801_CR23","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/hc4001.097056","volume":"104","author":"U Rueckschloss","year":"2001","unstructured":"Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy. Circulation. 2001;104(15):1767\u201372.","journal-title":"Circulation"},{"issue":"6","key":"801_CR24","first-page":"1745","volume":"108","author":"HC Ou","year":"2010","unstructured":"Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol (Bethesda, Md : 1985). 2010;108(6):1745\u201356.","journal-title":"J Appl Physiol (Bethesda, Md : 1985)"},{"issue":"9","key":"801_CR25","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/ATVBAHA.111.229260","volume":"31","author":"Y Shi","year":"2011","unstructured":"Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, et al. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2090\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"28","key":"801_CR26","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1074\/jbc.M708309200","volume":"283","author":"T Thum","year":"2008","unstructured":"Thum T, Borlak J. LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. J Biol Chem. 2008;283(28):19456\u201364.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"801_CR27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/BJ20050845","volume":"393","author":"J Chen","year":"2006","unstructured":"Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochem J. 2006;393(Pt 1):255\u201365.","journal-title":"Biochem J"},{"key":"801_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","volume":"27","author":"E Galkina","year":"2009","unstructured":"Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009;27:165\u201397.","journal-title":"Annu Rev Immunol"},{"issue":"25","key":"801_CR29","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1161\/01.CIR.101.25.2889","volume":"101","author":"D Li","year":"2000","unstructured":"Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101(25):2889\u201395.","journal-title":"Circulation"},{"issue":"6","key":"801_CR30","doi-asserted-by":"crossref","first-page":"C1329","DOI":"10.1152\/ajpcell.00513.2008","volume":"296","author":"MD Mattaliano","year":"2009","unstructured":"Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, et al. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol. 2009;296(6):C1329\u201337.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"801_CR31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.102.034959","volume":"302","author":"D Li","year":"2002","unstructured":"Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther. 2002;302(2):601\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"801_CR32","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2741\/1722","volume":"10","author":"H Zhu","year":"2005","unstructured":"Zhu H, Xia M, Hou M, et al. Ox-LDL plays dual effect in modulating expression of inflammatory molecules through LOX-1 pathway in human umbilical vein endothelial cells. Front Biosci. 2005;10:2585\u201394.","journal-title":"Front Biosci"},{"issue":"2","key":"801_CR33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2010.11.006","volume":"214","author":"A Pirillo","year":"2011","unstructured":"Pirillo A, Reduzzi A, Ferri N, Kuhn H, Corsini A, Catapano AL. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. Atherosclerosis. 2011;214(2):331\u20137.","journal-title":"Atherosclerosis"},{"issue":"2","key":"801_CR34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","volume":"102","author":"D Lievens","year":"2009","unstructured":"Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost. 2009;102(2):206\u201314.","journal-title":"Thromb Haemost"},{"issue":"5","key":"801_CR35","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000066685.13434.FA","volume":"23","author":"D Li","year":"2003","unstructured":"Li D, Liu L, Chen H, Sawamura T, Mehta JL. LOX-1, an oxidized LDL endothelial receptor, induces CD40\/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23(5):816\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"801_CR36","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9582430","volume":"2016","author":"YV Bobryshev","year":"2016","unstructured":"Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov AN. Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis. Biomed Res Int. 2016;2016:9582430.","journal-title":"Biomed Res Int"},{"issue":"Suppl 1","key":"801_CR37","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1097\/01.fjc.0000166243.43616.8b","volume":"44","author":"K Sakurai","year":"2004","unstructured":"Sakurai K, Cominacini L, Garbin U, Fratta Pasini A, Sasaki N, Takuwa Y, et al. Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J Cardiovasc Pharmacol. 2004;44(Suppl 1):S173\u201380.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"801_CR38","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1194\/jlr.M900167-JLR200","volume":"50","author":"DF Schaeffer","year":"2009","unstructured":"Schaeffer DF, Riazy M, Parhar KS, Chen JH, Duronio V, Sawamura T, et al. LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res. 2009;50(8):1676\u201384.","journal-title":"J Lipid Res"},{"issue":"5","key":"801_CR39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCRESAHA.109.194209","volume":"104","author":"D Li","year":"2009","unstructured":"Li D, Mehta JL. Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res. 2009;104(5):566\u20138.","journal-title":"Circ Res"},{"issue":"1\u20132","key":"801_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-5793(98)01414-8","volume":"440","author":"H Moriwaki","year":"1998","unstructured":"Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, Sawamura T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett. 1998;440(1\u20132):29\u201332.","journal-title":"FEBS Lett"},{"issue":"1","key":"801_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.atherosclerosis.2009.09.004","volume":"209","author":"J Ishiyama","year":"2010","unstructured":"Ishiyama J, Taguchi R, Yamamoto A, Murakami K. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells. Atherosclerosis. 2010;209(1):118\u201324.","journal-title":"Atherosclerosis"},{"issue":"7","key":"801_CR42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.0000124920.09738.26","volume":"94","author":"L Li","year":"2004","unstructured":"Li L, Sawamura T, Renier G. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res. 2004;94(7):892\u2013901.","journal-title":"Circ Res"},{"issue":"17","key":"801_CR43","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/eurheartj\/ehi282","volume":"26","author":"YV Bobryshev","year":"2005","unstructured":"Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J. 2005;26(17):1700\u20134.","journal-title":"Eur Heart J"},{"issue":"7","key":"801_CR44","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.4049\/jimmunol.167.7.3785","volume":"167","author":"L Perrin-Cocon","year":"2001","unstructured":"Perrin-Cocon L, Coutant F, Agaugue S, Deforges S, Andre P, Lotteau V. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol (Baltimore, Md : 1950). 2001;167(7):3785\u201391.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"3","key":"801_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00394-010-0125-8","volume":"50","author":"T Nickel","year":"2011","unstructured":"Nickel T, Hanssen H, Sisic Z, Pfeiler S, Summo C, Schmauss D, et al. Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr. 2011;50(3):163\u201372.","journal-title":"Eur J Nutr"},{"issue":"2","key":"801_CR46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2009.01.002","volume":"205","author":"T Nickel","year":"2009","unstructured":"Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, et al. oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis. 2009;205(2):442\u201350.","journal-title":"Atherosclerosis"},{"issue":"23 Suppl 1","key":"801_CR47","first-page":"Iii27","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):Iii27\u201332.","journal-title":"Circulation"},{"issue":"1","key":"801_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.218.25","volume":"218","author":"F Xu","year":"2009","unstructured":"Xu F, Sun Y, Chen Y, Sun Y, Li R, Liu C, et al. Endothelial cell apoptosis is responsible for the formation of coronary thrombotic atherosclerotic plaques. Tohoku J Exp Med. 2009;218(1):25\u201333.","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"801_CR49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.RES.0000113782.07824.BE","volume":"94","author":"J Chen","year":"2004","unstructured":"Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res. 2004;94(3):370\u20136.","journal-title":"Circ Res"},{"issue":"11","key":"801_CR50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1253\/circj.66.1060","volume":"66","author":"T Imanishi","year":"2002","unstructured":"Imanishi T, Hano T, Sawamura T, Takarada S, Nishio I. Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circ J. 2002;66(11):1060\u20134.","journal-title":"Circ J"},{"issue":"2","key":"801_CR51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2014.04.028","volume":"235","author":"D Hong","year":"2014","unstructured":"Hong D, Bai YP, Gao HC, Wang X, Li LF, Zhang GG, et al. Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway. Atherosclerosis. 2014;235(2):310\u20137.","journal-title":"Atherosclerosis"},{"issue":"17","key":"801_CR52","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1074\/jbc.M010612200","volume":"276","author":"L Cominacini","year":"2001","unstructured":"Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem. 2001;276(17):13750\u20135.","journal-title":"J Biol Chem"},{"issue":"45","key":"801_CR53","doi-asserted-by":"crossref","first-page":"32512","DOI":"10.1074\/jbc.274.45.32512","volume":"274","author":"A Blair","year":"1999","unstructured":"Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem. 1999;274(45):32512\u20139.","journal-title":"J Biol Chem"},{"issue":"40","key":"801_CR54","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/eht532","volume":"35","author":"A Akhmedov","year":"2014","unstructured":"Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C, et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. Eur Heart J. 2014;35(40):2839\u201348.","journal-title":"Eur Heart J"},{"issue":"11","key":"801_CR55","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCRESAHA.107.149724","volume":"100","author":"JL Mehta","year":"2007","unstructured":"Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007;100(11):1634\u201342.","journal-title":"Circ Res"},{"issue":"3","key":"801_CR56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.preghy.2012.04.077","volume":"2","author":"K Keman","year":"2012","unstructured":"Keman K, Rahardjo B, Madakusuma D. OS076. The effect of lectin-like oxidized low density lipoprotein receptor monoclonal antibody (LOX-1 MAb) on the expression of eNOS in preeclamptic HUVECs model. Pregnancy Hypertens. 2012;2(3):218\u20139.","journal-title":"Pregnancy Hypertens"},{"issue":"6620","key":"801_CR57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/386073a0","volume":"386","author":"T Sawamura","year":"1997","unstructured":"Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386(6620):73\u20137.","journal-title":"Nature"},{"issue":"8","key":"801_CR58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.CIR.100.8.783","volume":"100","author":"RL Silverstein","year":"1999","unstructured":"Silverstein RL, Nachman RL. Angiogenesis and atherosclerosis. The mandate broadens. Circulation. 1999;100(8):783\u20135.","journal-title":"Circulation"},{"key":"801_CR59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2040-2384-1-4","volume":"1","author":"M Slevin","year":"2009","unstructured":"Slevin M, Krupinski J, Badimon L. Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res. 2009;1:4\u20134.","journal-title":"J Angiogenes Res"},{"issue":"6","key":"801_CR60","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","volume":"90","author":"S Pitsilos","year":"2003","unstructured":"Pitsilos S, Hunt J, Mohler ER, Prabhakar A, Poncz M, Dawicki J, et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost. 2003;90(6):1112\u201320.","journal-title":"Thromb Haemost"},{"issue":"5","key":"801_CR61","first-page":"H2042","volume":"288","author":"T Matsunaga","year":"2005","unstructured":"Matsunaga T, Chilian WM, March K. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. Am J Phys Heart Circ Phys. 2005;288(5):H2042\u20136.","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"11","key":"801_CR62","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/ATVBAHA.107.152272","volume":"27","author":"A Dandapat","year":"2007","unstructured":"Dandapat A, Hu C, Sun L, Mehta JL. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol. 2007;27(11):2435\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"801_CR63","doi-asserted-by":"crossref","first-page":"e47421","DOI":"10.1371\/journal.pone.0047421","volume":"7","author":"Magomed Khaidakov","year":"2012","unstructured":"Khaidakov M, Mitra S, Wang X, Ding Z, Bora N, Lyzogubov V, et al. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One. 2012;7(10):\u2013e47421.","journal-title":"PLoS ONE"},{"key":"801_CR64","volume":"6","author":"Y Dai","year":"2016","unstructured":"Dai Y, Zhang Z, Cao Y, Mehta JL, Li J. MiR-590-5p inhibits oxidized- LDL induced angiogenesis by targeting LOX-1. Sci Rep. 2016;6:22607.","journal-title":"Sci Rep"},{"issue":"1","key":"801_CR65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bph.12897","volume":"172","author":"C Camar\u00e9","year":"2015","unstructured":"Camar\u00e9 C, Trayssac M, Garmy-Susini B, Mucher E, Sabbadini R, Salvayre R, et al. Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody. Br J Pharmacol. 2015;172(1):106\u201318.","journal-title":"Br J Pharmacol"},{"key":"801_CR66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2016.02.006","volume":"93","author":"C Camare","year":"2016","unstructured":"Camare C, Auge N, Pucelle M, et al. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL. Free Radic Biol Med. 2016;93:204\u201316.","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"801_CR67","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1074\/jbc.M708820200","volume":"283","author":"C Hu","year":"2008","unstructured":"Hu C, Dandapat A, Sun L, Khan JA, Liu Y, Hermonat PL, et al. Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem. 2008;283(16):10226\u201331.","journal-title":"J Biol Chem"},{"issue":"24","key":"801_CR68","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/CIRCULATIONAHA.113.007189","volume":"129","author":"MJ Mulligan-Kehoe","year":"2014","unstructured":"Mulligan-Kehoe MJ, Simons M. Vasa vasorum in normal and diseased arteries. Circulation. 2014;129(24):2557\u201366.","journal-title":"Circulation"},{"issue":"24","key":"801_CR69","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa035655","volume":"349","author":"FD Kolodgie","year":"2003","unstructured":"Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349(24):2316\u201325.","journal-title":"N Engl J Med"},{"issue":"18","key":"801_CR70","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/CIRCULATIONAHA.105.578955","volume":"113","author":"PR Moreno","year":"2006","unstructured":"Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006;113(18):2245\u201352.","journal-title":"Circulation"},{"issue":"12","key":"801_CR71","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852\u201366.","journal-title":"Circ Res"},{"issue":"2","key":"801_CR72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cvr\/cvn110","volume":"79","author":"C Hu","year":"2008","unstructured":"Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, et al. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res. 2008;79(2):287\u201393.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"801_CR73","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/erc.10.92","volume":"8","author":"P Aukrust","year":"2010","unstructured":"Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, et al. Activated platelets and atherosclerosis. Expert Rev Cardiovasc Ther. 2010;8(9):1297\u2013307.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"801_CR74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/bbrc.2001.4516","volume":"282","author":"M Chen","year":"2001","unstructured":"Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T, et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun. 2001;282(1):153\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"801_CR75","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1124\/jpet.107.122853","volume":"322","author":"MR Marwali","year":"2007","unstructured":"Marwali MR, Hu CP, Mohandas B, Dandapat A, Deonikar P, Chen J, et al. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther. 2007;322(3):1324\u201332.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"801_CR76","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.97.1.360","volume":"97","author":"M Kakutani","year":"2000","unstructured":"Kakutani M, Masaki T, Sawamura T. A platelet\u2013endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci. 2000;97(1):360\u20134.","journal-title":"Proc Natl Acad Sci"},{"key":"801_CR77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fphys.2015.00365","volume":"6","author":"DA Chistiakov","year":"2015","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol. 2015;6:365.","journal-title":"Front Physiol"},{"key":"801_CR78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.2000.tb06332.x","volume":"902","author":"N Kume","year":"2000","unstructured":"Kume N, Moriwaki H, Kataoka H, Minami M, Murase T, Sawamura T, et al. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells. Ann N Y Acad Sci. 2000;902:323\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"801_CR79","first-page":"36","volume":"39","author":"A Rudijanto","year":"2007","unstructured":"Rudijanto A. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state. Acta Med Indones. 2007;39(1):36\u201343.","journal-title":"Acta Med Indones"},{"key":"801_CR80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-09665-0_4","volume":"224","author":"E Favari","year":"2015","unstructured":"Favari E, Chroni A, Tietge UJ, Zanotti I, Escola-Gil JC, Bernini F. Cholesterol efflux and reverse cholesterol transport. Handb Exp Pharmacol. 2015;224:181\u2013206.","journal-title":"Handb Exp Pharmacol"},{"key":"801_CR81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj3340009","volume":"334","author":"H Yoshida","year":"1998","unstructured":"Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J. 1998;334 ( Pt 1:9\u201313.","journal-title":"Biochem J"},{"issue":"2","key":"801_CR82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.RES.0000174286.73200.d4","volume":"97","author":"K Inoue","year":"2005","unstructured":"Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res. 2005;97(2):176\u201384.","journal-title":"Circ Res"},{"issue":"4","key":"801_CR83","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cvr\/cvv178","volume":"107","author":"Z Ding","year":"2015","unstructured":"Ding Z, Liu S, Wang X, Deng X, Fan Y, Shahanawaz J, et al. Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovasc Res. 2015;107(4):556\u201367.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"801_CR84","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1248\/bpb.31.1475","volume":"31","author":"Y Kuge","year":"2008","unstructured":"Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, et al. Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull. 2008;31(8):1475\u201382.","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"801_CR85","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692\u2013702.","journal-title":"Circ Res"},{"issue":"2","key":"801_CR86","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbrc.2005.12.211","volume":"341","author":"H Eto","year":"2006","unstructured":"Eto H, Miyata M, Kume N, Minami M, Itabe H, Orihara K, et al. Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun. 2006;341(2):591\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"801_CR87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cardiores.2005.08.013","volume":"69","author":"J Hinagata","year":"2006","unstructured":"Hinagata J, Kakutani M, Fujii T, et al. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res. 2006;69(1):263\u201371.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"801_CR88","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.ATV.21.6.955","volume":"21","author":"H Kataoka","year":"2001","unstructured":"Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, et al. Oxidized LDL modulates Bax\/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21(6):955\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"801_CR89","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1172\/JCI118728","volume":"97","author":"G Murugesan","year":"1996","unstructured":"Murugesan G, Fox PL. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest. 1996;97(12):2736\u201344.","journal-title":"J Clin Invest"},{"issue":"2\u20133","key":"801_CR90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-5793(00)01154-6","volume":"467","author":"T Aoyama","year":"2000","unstructured":"Aoyama T, Chen M, Fujiwara H, Masaki T, Sawamura T. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett. 2000;467(2\u20133):217\u201320.","journal-title":"FEBS Lett"},{"issue":"15","key":"801_CR91","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.CIR.101.15.1799","volume":"101","author":"M Klouche","year":"2000","unstructured":"Klouche M, Rose-John S, Schmiedt W, Bhakdi S. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation. 2000;101(15):1799\u2013805.","journal-title":"Circulation"},{"issue":"2","key":"801_CR92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1527-3466.2007.00009.x","volume":"25","author":"XP Chen","year":"2007","unstructured":"Chen XP, Zhang TT, Du GH. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc Drug Rev. 2007;25(2):146\u201361.","journal-title":"Cardiovasc Drug Rev"},{"issue":"5","key":"801_CR93","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jvs.2010.04.085","volume":"52","author":"WJ Lee","year":"2010","unstructured":"Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg. 2010;52(5):1290\u2013300.","journal-title":"J Vasc Surg"},{"issue":"6","key":"801_CR94","doi-asserted-by":"crossref","first-page":"e65477","DOI":"10.1371\/journal.pone.0065477","volume":"8","author":"Lei Gu","year":"2013","unstructured":"Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y, et al. Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One. 2013;8(6):\u2013e65477.","journal-title":"PLoS ONE"},{"issue":"1\u20133","key":"801_CR95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.10.045","volume":"627","author":"A Taye","year":"2010","unstructured":"Taye A, Saad AH, Kumar AH, Morawietz H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol. 2010;627(1\u20133):42\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"801_CR96","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.trsl.2012.01.008","volume":"160","author":"S Xu","year":"2012","unstructured":"Xu S, Liu Z, Huang Y, Le K, Tang F, Huang H, et al. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-kappaB activation. Transl Res. 2012;160(2):114\u201324.","journal-title":"Transl Res"},{"issue":"12","key":"801_CR97","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/01.ATV.0000094411.98127.5F","volume":"23","author":"JL Mehta","year":"2003","unstructured":"Mehta JL, Hu B, Chen J, Li D. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol. 2003;23(12):2203\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"801_CR98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-9-16","volume":"9","author":"L Lu","year":"2010","unstructured":"Lu L, Liu H, Peng J, Gan L, Shen L, Zhang Q, et al. Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages. Lipids Health Dis. 2010;9:16.","journal-title":"Lipids Health Dis"},{"key":"801_CR99","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.biopha.2018.10.147","volume":"109","author":"Q Song","year":"2019","unstructured":"Song Q, Zhang Y, Han X, et al. Potential mechanisms underlying the protective effects of salvianic acid a against atherosclerosis in vivo and vitro. Biomed Pharmacother. 2019;109:945\u201356.","journal-title":"Biomed Pharmacother"},{"key":"801_CR100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2017.05.003","volume":"262","author":"TT Liu","year":"2017","unstructured":"Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice. Atherosclerosis. 2017;262:39\u201350.","journal-title":"Atherosclerosis"},{"issue":"23","key":"801_CR101","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1111\/bph.13068","volume":"172","author":"Z Liu","year":"2015","unstructured":"Liu Z, Xu S, Huang X, Wang J, Gao S, Li H, et al. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). Br J Pharmacol. 2015;172(23):5661\u201375.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"801_CR102","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/molecules23051101","volume":"23","author":"Qiu Li","year":"2018","unstructured":"Li Q, Zhao W, Zeng X, Hao Z. Ursolic acid attenuates atherosclerosis in ApoE(\u2212\/\u2212) mice: role of LOX-1 mediated by ROS\/NF-kappaB pathway. Molecules. 2018;23(5):1101\u201312.","journal-title":"Molecules"},{"issue":"9","key":"801_CR103","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jacc.2006.07.036","volume":"48","author":"SL Liu","year":"2006","unstructured":"Liu SL, Li YH, Shi GY, Chen YH, Huang CW, Hong JS, et al. A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice. J Am Coll Cardiol. 2006;48(9):1871\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"801_CR104","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fct.2015.04.028","volume":"82","author":"T Mohana","year":"2015","unstructured":"Mohana T, Navin AV, Jamuna S, Sakeena Sadullah MS, Niranjali Devaraj S. Inhibition of differentiation of monocyte to macrophages in atherosclerosis by oligomeric proanthocyanidins -in-vivo and in-vitro study. Food Chem Toxicol. 2015;82:96\u2013105.","journal-title":"Food Chem Toxicol"},{"key":"801_CR105","doi-asserted-by":"crossref","unstructured":"Zheng J, Liu B, Lun Q, et al. Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoE\u2212\/\u2212 mice by improving endothelial dysfunction. 2016;255:156\u201363.","DOI":"10.1016\/j.atherosclerosis.2016.08.022"},{"issue":"9","key":"801_CR106","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.nutres.2012.08.003","volume":"32","author":"J Minatti","year":"2012","unstructured":"Minatti J, Wazlawik E, Hort MA, Zaleski FL, Ribeiro-do-Valle RM, Maraschin M, et al. Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice. Nutr Res. 2012;32(9):684\u201393.","journal-title":"Nutr Res"},{"key":"801_CR107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vph.2017.10.004","volume":"100","author":"B Van der Veken","year":"2018","unstructured":"Van der Veken B, De Meyer GRY, Martinet W. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice. Vasc Pharmacol. 2018;100:34\u201340.","journal-title":"Vasc Pharmacol"},{"issue":"10","key":"801_CR108","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.metabol.2015.07.008","volume":"64","author":"L Wang","year":"2015","unstructured":"Wang L, Li G, Chen Q, Ke D. Octanoylated ghrelin attenuates angiogenesis induced by oxLDL in human coronary artery endothelial cells via the GHSR1a-mediated NF-kappaB pathway. Metabolism. 2015;64(10):1262\u201371.","journal-title":"Metabolism"},{"issue":"10","key":"801_CR109","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/15384101.2015.1026486","volume":"14","author":"S Biocca","year":"2015","unstructured":"Biocca S, Iacovelli F, Matarazzo S, Vindigni G, Oteri F, Desideri A, et al. Molecular mechanism of statin-mediated LOX-1 inhibition. Cell Cycle. 2015;14(10):1583\u201395.","journal-title":"Cell Cycle"},{"issue":"1\u20133","key":"801_CR110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2012.10.005","volume":"697","author":"H Zhang","year":"2012","unstructured":"Zhang H, Guo C, Zhang A, Fan Y, Gu T, Wu D, et al. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. Eur J Pharmacol. 2012;697(1\u20133):106\u201316.","journal-title":"Eur J Pharmacol"},{"key":"801_CR111","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijcard.2016.09.122","volume":"227","author":"T Becher","year":"2017","unstructured":"Becher T, Schulze TJ, Schmitt M, Trinkmann F, el-Battrawy I, Akin I, et al. Ezetimibe inhibits platelet activation and uPAR expression on endothelial cells. Int J Cardiol. 2017;227:858\u201362.","journal-title":"Int J Cardiol"},{"key":"801_CR112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2019.02.014","volume":"850","author":"G Wojcicka","year":"2019","unstructured":"Wojcicka G, Zareba M, Warpas A, et al. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats. Eur J Pharmacol. 2019;850:180\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"801_CR113","first-page":"85","volume":"627","author":"HS Lee","year":"2010","unstructured":"Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, et al. A noble function of BAY 11-7082: inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2\/JNK1 phosphorylations. Eur J Pharmacol. 2010;627(1\u20133):85\u201391.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"801_CR114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/09537104.2014.898747","volume":"26","author":"M Alarcon","year":"2015","unstructured":"Alarcon M, Fuentes E, Olate N, Navarrete S, Carrasco G, Palomo I. Strawberry extract presents antiplatelet activity by inhibition of inflammatory mediator of atherosclerosis (sP-selectin, sCD40L, RANTES, and IL-1beta) and thrombus formation. Platelets. 2015;26(3):224\u20139.","journal-title":"Platelets"},{"issue":"7","key":"801_CR115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/ijms18071500","volume":"18","author":"L-M Lien","year":"2017","unstructured":"Lien L-M, Lin K-H, Huang L-T, Tseng MF, Chiu HC, Chen RJ, et al. Licochalcone A prevents platelet activation and thrombus formation through the inhibition of PLC\u03b32-PKC, Akt, and MAPK pathways. Int J Mol Sci. 2017;18(7):1500.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"801_CR116","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1440-1681.12524","volume":"43","author":"L Qin","year":"2016","unstructured":"Qin L, Yang YB, Yang YX, Zhu N, Liu Z, Ni YG, et al. Inhibition of macrophage-derived foam cell formation by ezetimibe via the caveolin-1\/MAPK pathway. Clin Exp Pharmacol Physiol. 2016;43(2):182\u201392.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"801_CR117","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.biopha.2016.08.032","volume":"83","author":"W Yao","year":"2016","unstructured":"Yao W, Huang L, Sun Q, Yang L, Tang L, Meng G, et al. The inhibition of macrophage foam cell formation by tetrahydroxystilbene glucoside is driven by suppressing vimentin cytoskeleton. Biomed Pharmacother. 2016;83:1132\u201340.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"801_CR118","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.nano.2017.04.013","volume":"13","author":"JD Plotkin","year":"2017","unstructured":"Plotkin JD, Elias MG, Dellinger AL, Kepley CL. NF-kappaB inhibitors that prevent foam cell formation and atherosclerotic plaque accumulation. Nanomedicine. 2017;13(6):2037\u201348.","journal-title":"Nanomedicine"},{"issue":"2","key":"801_CR119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2017.06.020","volume":"490","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang S, Wang Z, Yun T, Wang C, Wang H. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice. Biochem Biophys Res Commun. 2017;490(2):194\u2013201.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"801_CR120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-017-3025-x","volume":"433","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Zhang D, Du B, Chen Z. Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway. Mol Cell Biochem. 2017;433(1\u20132):169\u201376.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"801_CR121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02857427","volume":"12","author":"YH Yu","year":"2006","unstructured":"Yu YH, Xu XQ, Wang Y, Sun SZ, Chen Y. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits. Chin J Integr Med. 2006;12(1):32\u20136.","journal-title":"Chin J Integr Med"},{"issue":"1","key":"801_CR122","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cellsig.2012.10.006","volume":"25","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Zhang M, Li Y, Liu S, Ping S, Wang J, et al. Simvastatin inhibits the additive activation of ERK1\/2 and proliferation of rat vascular smooth muscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway. Cell Signal. 2013;25(1):332\u201340.","journal-title":"Cell Signal"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-019-0801-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:19:17Z","timestamp":1595719157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-019-0801-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,27]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s11883-019-0801-y","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,27]]},"assertion":[{"value":"27 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sanjiv Singh, Avtar Singh Gautam declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"38"}}